Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tectonic Operating Company, Inc.

Clinical trials sponsored by Tectonic Operating Company, Inc., explained in plain language.

Now part of Tectonic Therapeutic, Inc. TECX NASDAQ

Biopharmaceutical company developing small molecule therapies for genetic diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New injection aims to ease lung pressure in scarred lungs

Disease control Recruiting now

This phase 2 trial tests an injected drug called TX000045 in 25 people who have high blood pressure in the lungs due to scarring lung disease. The main goal is to see if the drug lowers lung blood pressure and is safe over 16 weeks. Researchers will also check for side effects an…

Phase: PHASE2 • Sponsor: Tectonic Operating Company, Inc. • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC